BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
9/25/2025 11:24:06 AM | Browse: 77 | Download: 75
 |
Received |
|
2025-04-03 03:32 |
|
Peer-Review Started |
|
2025-04-06 08:16 |
 |
To Make the First Decision |
|
|
|
Return for Revision |
|
2025-04-25 09:30 |
|
Revised |
|
2025-05-22 06:54 |
|
Second Decision |
|
2025-09-09 02:43 |
|
Accepted by Journal Editor-in-Chief |
|
|
|
Accepted by Executive Editor-in-Chief |
|
2025-09-09 03:34 |
|
Articles in Press |
|
2025-09-09 03:34 |
|
Publication Fee Transferred |
|
|
|
Edit the Manuscript by Language Editor |
|
|
|
Typeset the Manuscript |
|
2025-09-17 06:25 |
|
Publish the Manuscript Online |
|
2025-09-25 11:24 |
| ISSN |
1948-5182 (online) |
| Open Access |
This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/Licenses/by-nc/4.0/ |
| Copyright |
© The Author(s) 2025. Published by Baishideng Publishing Group Inc. All rights reserved. |
| Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
| Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
| Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
| Website |
http://www.wjgnet.com |
| Category |
Surgery |
| Manuscript Type |
Minireviews |
| Article Title |
Postoperative adjuvant management in hepatocellular carcinoma: A review of therapeutic efficacy and prognostic outcomes
|
| Manuscript Source |
Invited Manuscript |
| All Author List |
Fei Liu, Jing Zhang and Kai Li |
| ORCID |
|
| Funding Agency and Grant Number |
| Funding Agency |
Grant Number |
| Lianyungang Comprehensive Cancer Management and Technology Advancement Project |
No. QN202302 |
| First People’s Hospital of Lianyungang Young Talent Development Initiative |
No. QN2212 |
| Jiangsu Society of Research Hospital Translational Medicine Research Grant |
No. 2024-GDZXKT-01-07 |
|
| Corresponding Author |
Kai Li, Adjunct Professor, Chief, Chief Physician, Department of Hepatobiliary Surgery, Lianyungang Clinical College of Nanjing Medical University, The First Affiliated Hospital of Kangda, College of Nanjing Medical University, The First People’s Hospital of Lianyungang, The Affiliated Lianyungang Hospital of Xuzhou Medical University, No. 6 Zhenhua East Road, Lianyungang 222061, Jiangsu Province, China. lkgdwk03178@163.com |
| Key Words |
Hepatocellular carcinoma; Recurrence post-surgery; Adjuvant therapy; High risk factors; Molecular targeted therapy; Traditional Chinese medicine; Targeted combination immunotherapy |
| Core Tip |
This article provides a comprehensive evaluation of postoperative adjuvant therapies for hepatocellular carcinoma in patients at high risk of recurrence, detailing the clinical advantages of diverse diagnostic and therapeutic modalities. It highlights the significance and challenges of adjuvant treatment, highlighting the necessity and benefits of multimodal strategies and interdisciplinary collaboration. These insights aim to improve prognosis, extend survival, and inform personalized adjuvant therapy following liver cancer resection. |
| Publish Date |
2025-09-25 11:24 |
| Citation |
<p>Liu F, Zhang J, Li K. Postoperative adjuvant management in hepatocellular carcinoma: A review of therapeutic efficacy and prognostic outcomes. <i>World J Hepatol</i> 2025; 17(9): 107631</p> |
| URL |
https://www.wjgnet.com/1948-5182/full/v17/i9/107631.htm |
| DOI |
https://dx.doi.org/10.4254/wjh.v17.i9.107631 |
© 2004-2025 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
California Corporate Number: 3537345
